First Allied Advisory Services’s OncoSec Medical Incorporated ONCS Stock Holding History

First Allied Advisory Services’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-159	Closed	-$19K	–	1260
2019 Q1	$19K	Hold	159	–	–	﹤0.01%	1148
2018 Q4	$22K	Hold	159	–	–	﹤0.01%	1064
2018 Q3	$49K	Hold	159	–	–	﹤0.01%	1165
2018 Q2	$48K	Sell	159 -3	-2%	-$1.05K	﹤0.01%	1132
2018 Q1	$67K	Hold	162	–	–	﹤0.01%	1142
2017 Q4	$58K	Hold	162	–	–	﹤0.01%	1283
2017 Q3	$35K	Hold	162	–	–	﹤0.01%	1108
2017 Q2	$43K	Buy	+162	New	+$39.7K	﹤0.01%	1124

Other funds holding ONCS

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Allied Advisory Services's ONCS Position: Q2 2019 in Review

First Allied Advisory Services sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 159 shares — an estimated $19K sold.

First Allied Advisory Services first reported a position in ONCS in Q2 2017 and held it in 8 quarters. The position peaked at $67K in Q1 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

First Allied Advisory Services reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
First Allied Advisory Services sold 159 OncoSec Medical Incorporated shares in Q2 2019, an estimated $19K.
First Allied Advisory Services first reported a position in OncoSec Medical Incorporated in Q2 2017 and held it in 8 quarters.
First Allied Advisory Services's OncoSec Medical Incorporated position peaked at $67K in Q1 2018.
20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on First Allied Advisory Services's 13F filing for Q2 2019, filed 12 Aug 2019.